Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Choi, Jae Yoo ^a   Gwon, Yong Dae ^a   Kim, Jeong Ki ^b,e   Cho, Yeon Dong ^a   Heo, Yoon Ki ^a   Cho, Han Sam ^a   Choi, Tae Jin ^c   Poo, Ha Ryoung ^b   Oh, Yu Kyoung ^d   Kim, Young Bong ^a  

^a Konkuk University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Pukyong National University   (South Korea)

^d Seoul National University   (South Korea)

^e Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BACULOVIRIDAE; CELL LINE; ENDOGENOUS RETROVIRUSES; FEMALE; GENE EXPRESSION; GENE ORDER; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; LUNG; MICE; ORTHOMYXOVIRIDAE INFECTIONS; VIRAL ENVELOPE PROTEINS;

EID: 84894035078     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080762     Document Type: Article

References (34)

1. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939. doi:10.1038/nature08157. PubMed: 19525932.
2. Arias CF, Escalera-Zamudio M, Rio Mde Soto-Del Cobian-Guemes AG L, Isa P, et al. (2009) Molecular anatomy of 2009 influenza virus A (H1N1). Arch Med Res 40: 643-654.
3. Ehrhardt C, Seyer R, Hrincius ER, Eierhoff T, Wolff T et al. (2010) Interplay between influenza A virus and the innate immune signaling. Microbes Infect 12: 81-87. doi:10.1016/j.micinf.2009.09.007. PubMed: 19782761.
4. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD et al. (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324: 1557-1561. doi:10.1126/science.1176062. PubMed: 19433588.
5. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S et al. (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79: 2814-2822. doi:10.1128/JVI.79.5. 2814-2822.2005. PubMed: 15709000. (Pubitemid 40270559)
6. Tong S, Li Y, Rivailler P, Conrardy C, Castillo DA et al. (2012) A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A 109: 4269-4274. doi:10.1073/pnas.1116200109. PubMed: 22371588.
7. WHO website. Available: http://www.who.int/csr/don/2010-08-06/en/index. html. Accessed 2010 August 6.
8. McPherson CE (2008) Development of a novel recombinant influenza vaccine in insect cells. Biologicals 36: 350-353. doi:10.1016/j.biologicals.2008.08.001. PubMed: 18804387.
9. Audsley JM, Tannock GA (2008) Cell-based influenza vaccines: progress to date. Drugs 68: 1483-1491. doi:10.2165/00003495-200868110-00002. PubMed: 18627206. (Pubitemid 352001186)
10. Du L, Zhou Y, Jiang S (2010) Research and development of universal influenza vaccines. Microbes Infect 12: 280-286. doi:10.1016/j.micinf.2010.01. 001. PubMed: 20079871.
11. Khurana S, Wu J, Verma N, Verma S, Raghunandan R et al. (2011) H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans. J Virol 85: 10945-10954. doi:10.1128/JVI.05406-11. PubMed: 21865396.
12. Liu F, Ge S, Li L, Wu X, Liu Z et al. (2012) Virus-like particles: potential veterinary vaccine immunogens. Res Vet Sci 93: 553-559. doi:10.1016/j.rvsc.2011.10.018. PubMed: 22100244.
13. Jiang Y, Yu K, Zhang H, Zhang P, Li C et al. (2007) Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antiviral Res 75: 234-241. doi:10.1016/j.antiviral. 2007.03.009. PubMed: 17451817. (Pubitemid 46908751)
14. Glenting J, Wessels S (2005) Ensuring safety of DNA vaccines. Microb Cell Factories 4: 26. doi:10.1186/1475-2859-4-26. PubMed: 16144545.
15. Liu MA (2011) DNA vaccines: an historical perspective and view to the future. Immunol Rev 239: 62-84. doi:10.1111/j.1600-065X.2010.00980.x. PubMed: 21198665.
16. Syed MS, Kwang J (2011) Oral vaccination of baculovirus-expressed VP28 displays enhanced protection against White Spot Syndrome Virus in Penaeus monodon. PLOS ONE 6: e26428. doi:10.1371/journal.pone.0026428. PubMed: 22069450.
17. Kost TA, Condreay JP, Jarvis DL (2005) Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23: 567-575. doi:10.1038/nbt1095. PubMed: 15877075. (Pubitemid 41724895)
18. Wu Q, Fang L, Wu X, Li B, Luo R et al. (2009) A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens. Mol Immunol 46: 2210-2217. doi:10.1016/j.molimm.2009.04.017. PubMed: 19446339.
19. Lee HJ, Park N, Cho HJ, Yoon JK, Van ND et al. (2010) Development of a novel viral DNA vaccine against human papillomavirus: AcHERVHP16L1. Vaccine 28: 1613-1619. doi:10.1016/j.vaccine.2009.11.044. PubMed: 19961961.
20. Lee HJ, Hur YK, Cho YD, Kim MG, Lee HT et al. (2012) Immunogenicity of bivalent human papillomavirus DNA vaccine using human endogenous retrovirus envelope-coated baculoviral vectors in mice and pigs. PLOS ONE 7: e50296. doi:10.1371/journal.pone.0050296. PubMed: 23209698.
21. Bouvier NM, Lowen AC (2010) Animal Models for Influenza Virus Pathogenesis and Transmission. Viruses 2: 1530-1563. doi:10.3390/v20801530. PubMed: 21442033.
22. Chang H, Huang C, Wu J, Fang F, Zhang W et al. (2010) A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus. Virol J 7: 197. doi:10.1186/1743-422X-7-197. PubMed: 20727202.
23. Ghosh S, Parvez MK, Banerjee K, Sarin SK, Hasnain SE (2002) Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy. Mol Ther 6: 5-11. doi:10.1006/mthe.2000.0643. PubMed: 12095297. (Pubitemid 36124264)
24. Smagghe G, Goodman CL, Stanley D (2009) Insect cell culture and applications to research and pest management. In Vitro Cell Dev Biol Anim 45: 93-105. doi:10.1007/s11626-009-9181-x. PubMed: 19247722.
25. Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P et al. (1995) Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci U S A 92: 10099-10103. doi:10.1073/pnas.92.22.10099. PubMed: 7479733.
26. Gao H, Wang Y, Li N, Peng WP, Sun Y et al. (2007) Efficient gene delivery into mammalian cells mediated by a recombinant baculovirus containing a whispovirus ie1 promoter, a novel shuttle promoter between insect cells and mammalian cells. J Biotechnol 131: 138-143. doi:10.1016/j.jbiotec.2007.06.002. PubMed: 17640755. (Pubitemid 47187507)
27. Chen CY, Lin CY, Chen GY, Hu YC (2011) Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol Adv 29: 618-631. doi:10.1016/j.biotechadv.2011. 04.004. PubMed: 21550393.
28. DePolo NJ, Reed JD, Sheridan PL, Townsend K, Sauter SL et al. (2000) VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2: 218-222. doi:10.1006/mthe.2000.0116. PubMed: 10985952.
29. Ory DS, Neugeboren BA, Mulligan RC (1996) A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A 93: 11400-11406. doi:10.1073/pnas.93.21.11400. PubMed: 8876147. (Pubitemid 26347133)
30. Huang CY, Chen JJ, Shen KY, Chang LS, Yeh YC et al. (2012) Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model. PLOS ONE 7: e40970. doi:10.1371/journal.pone.0040970. PubMed: 22815882.
31. Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D et al. (1999) Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A 96: 1036-1041. doi:10.1073/pnas.96.3. 1036. PubMed: 9927689.
32. Liu T, Matsuguchi T, Tsuboi N, Yajima T, Yoshikai Y (2002) Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect Immun 70: 6638-6645. doi:10.1128/IAI.70.12.6638- 6645.2002. PubMed: 12438336. (Pubitemid 35387892)
33. Matos I, Mizenina O, Lubkin A, Steinman RM, Idoyaga J (2013) Correction: Targeting Antigens to Dendritic Cells In Vivo Induces Protective Immunity. PLOS ONE 8.
34. Cho HJ, Lee S, Im S, Kim MG, Lee J et al. (2012) Preclinical pharmacokinetics and biodistribution of human papillomavirus DNA vaccine delivered in human endogenous retrovirus envelope-coated baculovirus vector. Pharm Res 29: 585-593. doi:10.1007/s11095-011-0598-z. PubMed: 21948385.